Suppression of melanogenesis by a newly synthesized compound, MHY966 via the nitric oxide/protein kinase G signaling pathway in murine skin
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- JOURNAL OF DERMATOLOGICAL SCIENCE68(3) · pp.164 · 2012
- 피인용
- Web of Science 26
- JCR IF
- JCR 2011 3.718
- ISSN
- 0923-1811
저자
- 최연자제1저자부산대학교, 약학대학, 약학부, 약학전공, KO
- 우에하라요우에이부산대학교, 약학대학, 약학부, KO
- 박지영부산대학교, 약학대학, 약학부, 제약학전공, KO
- 정기웅부산대학교, 약학대학, 약학부, 약학전공, KO
- 하영미부산대학교, 부속연구소, 분자염증노화제어연구센터, KO
- 김지민부산대학교, 약학대학, 약학부, 약학전공, KO
- 송유민부산대학교, 약학대학, 약학부, 제약학전공, KO
- Chun, Pusoon인제대학교, Coll Pharm, Gimhae 621749, KO
- 박준환부산대학교, 약학대학, 약학부, KO
- 문형룡교신저자부산대학교, 약학대학, 약학부, 제약학전공, KO
- 정해영교신저자부산대학교, 약학대학, 약학부, 약학전공, KO
초록
Background: Ultraviolet B (UVB) radiation is the main physiological stimulus for skin pigmentation. Nitric oxide (NO) and the NO/PKG signaling pathway play an important role in UVB-induced melanogenesis, which is related to the induction of expression of tyrosinase. In an attempt to find a novel anti-melanogenic agent, we synthesized a new compound, 2-bromo-4-(5-chloro-benzo[d]thiazol-2-yl) phenol (MHY966). Objective: The purpose of this study was to investigate the action of MHY966 on NO and the NO-mediated signaling pathway using in vitro and in vivo models of melanogenesis. Methods: NO generation, melanin synthesis, and the expression of tyrosinase and PKG were measured in B16F10 melanoma cells to verify the anti-melanogenic effect of MHY966 in vitro. Next, melanin-possessing hairless mice were pre-treated with MHY966 and then irradiated with UVB repeatedly. Morphological, histological, and biochemical analyses including the expressions of PKG, tryosinase and nuclear MITF, and productions of nitric oxide, peroxynitrite and ROS were conducted. Results: MHY966 effectively inhibited NO generation and subsequent melanin synthesis induced by sodium nitroprusside, an NO donor, and suppressed the expression of tyrosinase and PKG. Topical application of MHY966 dose-dependently attenuated UVB-induced pigmentation in a mouse model. This hypopigmentation effect induced by MHY966 treatment was mediated by the down-regulation of tyrosinase, PKG, and nuclear MITF, which was accompanied by decreased NO and NO-related oxidative stress. Conclusion: The novel compound, MHY966 had an inhibitory effect on NO generation and the NO-mediated signaling pathway leading to the down-regulation of tyrosinase. The significance of the present study is the finding of a promising anti-melanogenic agent targeting the NO/PKG signaling pathway. (C) 2012 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
키워드
Nitric oxideMHY966MelanogenesisPKGTyrosinaseHUMAN MELANOCYTESANTIOXIDANT DEFENSETYROSINASE GENEOXIDEPIGMENTATIONACIDKERATINOCYTESMODULATIONSYSTEM
식별자
- WoS UID
- 000311711300006



로그인
연구물 목록으로